]>C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients : Table 3
Table 3: Erythrocyte elongation index (EI) (%) in the shear stress range 0.6–12 Pa for different treatment groups, 𝑛 = 2 3 .
Shear stress
0.6 Pa1.2 Pa3 Pa6 Pa12 Pa
Healthy controls 5 . 8 7 ± 0 . 7 2 ∗ 1 4 . 3 7 ± 0 . 6 1 ∗ 2 9 . 0 8 ± 0 . 7 9 ∗ 3 9 . 1 9 ± 1 . 0 2 ∗ 4 5 . 9 3 ± 0 . 8 5 ∗
Diabetes patients 4 . 3 8 ± 0 . 6 3 1 1 . 7 7 ± 0 . 4 9 2 6 . 0 1 ± 0 . 6 0 3 5 . 4 8 ± 0 . 8 4 4 3 . 3 4 ± 0 . 9 2
C-peptide 5 . 4 0 ± 0 . 8 2 ∗ 1 4 . 1 1 ± 0 . 8 5 ∗ 2 8 . 3 4 ± 1 . 5 8 ∗ 3 9 . 0 7 ± 1 . 4 6 ∗ 4 5 . 8 2 ± 1 . 4 3 ∗
HP 5 . 7 7 ± 0 . 8 1 ∗ 1 4 . 1 8 ± 1 . 1 7 ∗ 2 8 . 6 1 ± 1 . 3 7 ∗ 3 8 . 4 9 ± 1 . 6 2 ∗ 4 5 . 8 2 ± 1 . 8 1 ∗
PP 6 . 1 2 ± 0 . 9 3 ∗ 1 4 . 0 2 ± 1 . 3 7 ∗ 2 8 . 2 3 ± 1 . 4 6 ∗ 3 8 . 8 5 ± 1 . 5 4 ∗ 4 5 . 2 0 ± 1 . 7 4 ∗
MF 4 . 4 2 ± 0 . 8 9 1 1 . 3 9 ± 1 . 0 7 2 5 . 8 2 ± 1 . 2 4 3 5 . 7 9 ± 0 . 9 8 4 3 . 3 9 ± 1 . 1 7
SCR 4 . 1 0 ± 0 . 9 1 1 1 . 2 5 ± 1 . 0 7 2 5 . 5 8 ± 1 . 0 7 3 5 . 6 4 ± 0 . 9 1 4 3 . 4 8 ± 1 . 0 0
∗ 𝑃 < . 0 1 versus type 1 diabetes patients.